COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC

NCT04068610 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Microsatellite-stable Colorectal Cancer

Interventions

DRUG: Durvalumab
DRUG: Oleclumab
DRUG: FOLFOX
DRUG: Bevacizumab

Sponsor

MedImmune LLC